Protagen

Dortmund, Germany Founded: 1997 • Age: 29 yrs Acquired By Oncimmune
Autoantibody biomarkers are utilized for autoimmune disease diagnostics.
Request Access

About Protagen

Protagen is a company based in Dortmund (Germany) founded in 1997 was acquired by Oncimmune in March 2019.. Protagen has raised $19.84 million across 6 funding rounds from investors including Qiagen, NRW.Bank and Oncimmune. The company has 20 employees as of December 31, 2017. Protagen operates in a competitive market with competitors including HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Kypha, among others.

  • Headquarter Dortmund, Germany
  • Employees 20 as on 31 Dec, 2017
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Protagen Ag
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $19.84 M (USD)

    in 6 rounds

  • Latest Funding Round
  • Investors
    Qiagen

    & 6 more

  • Employee Count
    20

    as on Dec 31, 2017

  • Acquired by
    Oncimmune

    (Mar 19, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Protagen

Protagen has successfully raised a total of $19.84M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round
  • First Round

    (14 Apr 2005)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2014 Amount Series D - Protagen Valuation

investors

Sep, 2010 Amount Series D - Protagen Valuation

investors

Aug, 2008 Amount Series C - Protagen Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Protagen

Protagen has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Qiagen, NRW.Bank and Oncimmune. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital investments in technology companies are managed by MIG Fonds.
Founded Year Domain Location
VC Firm funding companies in Europe
Founded Year Domain Location
Products and reagents for molecular diagnostic assays are supplied.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Protagen

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Protagen

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Protagen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Protagen

Protagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Kypha, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
domain founded_year HQ Location
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
domain founded_year HQ Location
T-cell-based diagnostics for infectious and immune diseases are developed.
domain founded_year HQ Location
Tools for diagnosing immune-mediated inflammatory diseases are developed.
domain founded_year HQ Location
Diagnostic biomarker tests for inflammation and autoimmune diseases are developed.
domain founded_year HQ Location
Provider of immune monitoring reagents and services for research and clinical use
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Protagen

Frequently Asked Questions about Protagen

When was Protagen founded?

Protagen was founded in 1997 and raised its 1st funding round 8 years after it was founded.

Where is Protagen located?

Protagen is headquartered in Dortmund, Germany. It is registered at Dortmund, North Rhine-westphalia, Germany.

Is Protagen a funded company?

Protagen is a funded company, having raised a total of $19.84M across 6 funding rounds to date.

How many employees does Protagen have?

As of Dec 31, 2017, the latest employee count at Protagen is 20.

What does Protagen do?

Protagen is a provider of services, products and software solutions for protein research. Protagen provides products and GMP compliant services. The patented platform of protein expression libraries UNIclone allows Protagen the development of a new class of diagnostics based on autoantibody signatures in blood. Utilizing a personalized medicine approach, their multi-marker assay technology SeroTag; enables differential diagnosis and patient stratification for Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis and others. Protagen launched a research test in July 2014 for Systemic Sclerosis, secured by strong IP coverage and validated by proof-of concept studies in thousands of clinical samples.

Who are the top competitors of Protagen?

Protagen's top competitors include Exagen, SmartHealth and HYCOR BioMedical.

Who are Protagen's investors?

Protagen has 7 investors. Key investors include Qiagen, NRW.Bank, Oncimmune, KfW, and MIG Fonds.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available